0001209191-18-058608.txt : 20181114
0001209191-18-058608.hdr.sgml : 20181114
20181114181054
ACCESSION NUMBER: 0001209191-18-058608
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181114
FILED AS OF DATE: 20181114
DATE AS OF CHANGE: 20181114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pedder Simon
CENTRAL INDEX KEY: 0001316736
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 181185437
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-14
0
0001300699
Athenex, Inc.
ATNX
0001316736
Pedder Simon
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
0
1
0
0
See Remarks
Common Stock
2018-11-14
4
P
0
2908
10.258
A
3908
D
Stock Option (Right to Buy)
4.55
2023-05-13
Common Stock
20000
20000
D
Stock Option (Right to Buy)
9.00
2026-02-28
Common Stock
100000
100000
D
Stock Option (Right to Buy)
11.00
2027-06-13
Common Stock
130000
130000
D
This transaction was executed in multiple trades ranging from $10.250 to $10.259. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
The option vests in four equal annual installments beginning on May 13, 2014.
The option vests in four equal annual installments beginning on February 28, 2017.
The option vests in four equal annual installments beginning on June 13, 2018.
/s/Teresa Bair, Attorney-in-Fact
2018-11-14